Home/Unravel Biosciences/Richard Novak, PhD
RN

Richard Novak, PhD

CEO & Co-Founder

Unravel Biosciences

Unravel Biosciences Pipeline

DrugIndicationPhase
RVL-001 (vorinostat)Rett SyndromeClinical Trial Initiated
New Chemical EntityRett Syndrome and other disordersPre-clinical